2016
DOI: 10.1155/2016/5091838
|View full text |Cite
|
Sign up to set email alerts
|

Cell‐Based Therapy for Silicosis

Abstract: Silicosis is the most common pneumoconiosis globally, with higher prevalence and incidence in developing countries. To date, there is no effective treatment to halt or reverse the disease progression caused by silica-induced lung injury. Significant advances have to be made in order to reduce morbidity and mortality related to silicosis. In this review, we have highlighted the main mechanisms of action that cause lung damage by silica particles and summarized the data concerning the therapeutic promise of cell… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
67
0
4

Year Published

2017
2017
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 84 publications
(71 citation statements)
references
References 100 publications
(104 reference statements)
0
67
0
4
Order By: Relevance
“…The mechanism that orchestrates silica‐induced lung damage involves direct cellular toxicity, an imbalance in oxidative stress enzymes, and the release of inflammatory and fibrotic cytokines 8–10 . The inflammatory response has been described as essential to the pathogenesis of silicosis, both in human studies and in experimental animal models.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…The mechanism that orchestrates silica‐induced lung damage involves direct cellular toxicity, an imbalance in oxidative stress enzymes, and the release of inflammatory and fibrotic cytokines 8–10 . The inflammatory response has been described as essential to the pathogenesis of silicosis, both in human studies and in experimental animal models.…”
Section: Introductionmentioning
confidence: 99%
“…7 The mechanism that orchestrates silica-induced lung damage involves direct cellular toxicity, an imbalance in oxidative stress enzymes, and the release of inflammatory and fibrotic cytokines. [8][9][10] The inflammatory response has been described as essential to the pathogenesis of silicosis, both in human studies and in experimental animal models. The activation and recruitment of macrophages and neutrophils into the lung parenchyma, particularly on the NALP-3 inflammasome, drives the production of inflammatory cytokines and chemokines, thus promoting and intensifying local tissue damage that culminates in collagen and elastin deposition and lung remodeling.…”
Section: Introductionmentioning
confidence: 99%
“…90 Cell-based therapy including bone marrow-derived mononuclear cell 91 and mesenchymal cell transplantation 92 have both demonstrated some benefit in animal models and are currently undergoing trials in humans. 93…”
Section: Antifibrotic Therapymentioning
confidence: 99%
“…To date, there is no efective treatment to halt or reverse the disease progression caused by silica-induced lung injury [19]. Efective therapies have to be found in order to reduce morbidity and mortality related to silicosis.…”
Section: Silicosis and Qi Deiciencymentioning
confidence: 99%